RBPJ Inhibitor-1是一种新型小分子抑制剂,可干扰 NOTCH 与 RBPJ 的相互作用。它还可以阻断 RBPJ 与 SHARP(一种支架蛋白)之间的功能性相互作用,后者在没有 NOTCH 信号的情况下与 RBPJ 形成转录抑制复合物。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | NOTCH proteins are trans-membrane receptors that transduce signals from cell-bound JAGGED (JAG) and Delta-like (DLL) families of ligands to mediate cell-cell interactions in processes as diverse as fetal development, heart disease and cancer. NOTCH is cleaved by γ-secretase after activation to release an intracellular domain (NICD) that binds the transcriptional effector RBPJ. RBPJ inhibitor-1 (RIN1) is the first inhibitor of RBPJ which potently disrupts the functional interaction of RBPJ with NOTCH. RIN1 inhibited Hes1-Luciferase, NOTCH3 ICD and RBPJ-VP16-dependent Hes1-Luciferase with IC50s of 0.18, 0.19, and 0.2 µM and Emaxs of 82%, 88% and 81%, respectively. RIN1 (2 µM) decreased RBPJ-VP16-dependent Hes1-Luciferase activity and caused a corresponding decrease in Luciferase reporter mRNA and endogenous RBPJ target gene expression mRNAs. RIN1 decreased cell proliferation in Jurkat, Koptk-1 and Rec-1 cancer cell lines. RIN1 (0.6 µM) decreased the number of MHC+ cells and increased the number of nuclei per cell, indicating that it induced the formation of multinucleated myofibers[2]. |
Concentration | Treated Time | Description | References | |
C2C12 myoblasts | 0.6 µM | 4 days | RIN1 promoted the differentiation of C2C12 myoblasts into multinucleated myofibers. | Sci Rep. 2019 Jul 25;9(1):10811. |
Jurkat cells | 2 µM | 8 h | RIN1 suppressed the proliferation of Jurkat cells and induced gene expression changes similar to RBPJ silencing. | Sci Rep. 2019 Jul 25;9(1):10811. |
T lymphocytes | 2 μM | 24 h | To validate the effect of Notch pathway inactivation on Th cell differentiation and apoptosis in patients with uveitis. Results showed that after RIN1 treatment, the expression of Dll4 and RBPJ was significantly reduced, the proportion of Th17/Treg, CD4+/CD8+, and apoptotic cell levels decreased, while mitochondrial membrane potential levels increased. | J Transl Med. 2025 Apr 10;23(1):426. |
Peripheral blood CD8+ T cells | 10 µM | 96 h | To investigate the synergistic regulation of Notch and TGF-β signaling pathways on the differentiation of DP CD8+ TRM cells. Results showed that the addition of DLL4 and TGF-β1 significantly increased CD103 expression, while the addition of RIN1 decreased CD103 expression. | Cell Commun Signal. 2024 Dec 18;22(1):608. |
C2C12 myoblasts | 0.6 µM | 4 days | Promoted muscle cell differentiation into multinucleated myofibers | Sci Rep. 2019 Jul 25;9(1):10811. |
Jurkat cells | 2 µM | 8 h | Compared transcriptomic effects of RIN1, DAPT, and CB-103, RIN1 inhibited cell proliferation | Sci Rep. 2019 Jul 25;9(1):10811. |
AD-293 cells | 10 µM | 17 h | Primary screen for RBPJ inhibitors, RIN1 inhibited UAS-Luc activity | Sci Rep. 2019 Jul 25;9(1):10811. |
Administration | Dosage | Frequency | Description | References | ||
BALB/c nude mice | 786-O renal cancer cell xenograft model | Intraperitoneal injection | 40 mg/kg | Combination of RBPJ inhibitors with CDK4/6 inhibitors showed synergistic effects on renal cancer cells. | Cell Death Dis. 2022 Apr 2;13(4):295 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.21mL 0.64mL 0.32mL |
16.06mL 3.21mL 1.61mL |
32.12mL 6.42mL 3.21mL |
CAS号 | 2682114-39-0 |
分子式 | C17H14FN3O2 |
分子量 | 311.31 |
SMILES Code | FC1=CC=CC=C1OC2=C(C(N)=O)C=CC(C3=CC=NN3C)=C2 |
MDL No. | MFCD32856863 |
别名 | RIN1 |
运输 | 蓝冰 |
InChI Key | MFSSHRCJKRDIOL-UHFFFAOYSA-N |
Pubchem ID | 146019721 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
溶解方案 |
DMSO: 250 mg/mL(803.06 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|